| Chairman |
|
Lou Jing |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman, Chief Executive Officer & President: Lou Jing
Executive Director: Su Dongmei
Non-executive Director: Zhang Jiaoe
Independent Non-executive Director: Pu Tianruo, Yang Hoi Ti Heidi , Ng Joo Yeow Gerry.
|
| Principle Business |
|
The Group is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the PRC. |
| Related Indexes | | Hang Seng Healthcare Index | Hang Seng Biotech Index | | HKEX Tech 100 Index | HS China (HK-listed) 100 Index | | Hang Seng Healthcare Industry Index | Hang Seng Composite MidCap Index | | Hang Seng Composite Index |
|
| Major Shareholders |
| Lou Jing & ASSO | 534,249,001 | 21.13% | 2026/09/07 | | 149,996,000 | 5.90% | 2026/09/29 |
|
|
|
|